Eagle Bay Advisors LLC Has $135,000 Position in The Cooper Companies, Inc. (NASDAQ:COO)

Eagle Bay Advisors LLC lessened its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 11.8% during the fourth quarter, Holdings Channel reports. The fund owned 1,470 shares of the medical device company’s stock after selling 197 shares during the quarter. Eagle Bay Advisors LLC’s holdings in Cooper Companies were worth $135,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the stock. Fulton Bank N.A. lifted its position in shares of Cooper Companies by 3.0% during the 4th quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after acquiring an additional 109 shares during the period. Mitchell & Pahl Private Wealth LLC increased its stake in Cooper Companies by 1.5% during the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 7,986 shares of the medical device company’s stock valued at $881,000 after purchasing an additional 117 shares in the last quarter. Commonwealth Equity Services LLC increased its stake in Cooper Companies by 0.8% during the 2nd quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company’s stock valued at $1,362,000 after purchasing an additional 118 shares in the last quarter. Bleakley Financial Group LLC increased its stake in Cooper Companies by 2.1% during the 3rd quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company’s stock valued at $636,000 after purchasing an additional 119 shares in the last quarter. Finally, Empirical Finance LLC increased its stake in Cooper Companies by 2.2% during the 3rd quarter. Empirical Finance LLC now owns 6,786 shares of the medical device company’s stock valued at $749,000 after purchasing an additional 145 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of Cooper Companies stock traded up $0.18 on Monday, reaching $90.49. The stock had a trading volume of 658,545 shares, compared to its average volume of 1,108,057. The business’s 50 day moving average is $97.84 and its two-hundred day moving average is $98.91. The company has a market cap of $18.06 billion, a P/E ratio of 46.41, a price-to-earnings-growth ratio of 2.40 and a beta of 0.99. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Cooper Companies’s quarterly revenue was up 9.8% on a year-over-year basis. During the same period last year, the firm posted $0.87 earnings per share. As a group, research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analysts Set New Price Targets

COO has been the subject of several recent analyst reports. Citigroup reduced their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Morgan Stanley reduced their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Finally, Wells Fargo & Company increased their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.